You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,689,761


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,689,761
Title: Combination therapy for HIV infection
Abstract:The combination of the HIV protease inhibitor Compound J, 3TC, and, optionally AZT, ddI, or ddC, is useful in the inhibition of HIV protease, the inhibition of HIV reverse transcriptase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Inventor(s): Chodakewitz; Jeffrey A. (Gwynedd Valley, PA), Emini; Emilio A. (Paoli, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/382,113
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,689,761: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for both patent holders and those seeking to navigate the intellectual property landscape. This article will delve into the specifics of United States Patent 6,689,761, exploring its background, claims, and the broader patent landscape it inhabits.

Background of U.S. Patent 6,689,761

To analyze the patent, it is essential to start with its background. U.S. Patent 6,689,761, like other patents, is part of a larger family of patents that may include continuations, continuations-in-part, and divisional applications. Each of these patents can have its own unique claims and expiration dates, influenced by factors such as Patent Term Adjustment (PTA) and Patent Term Extension (PTE)[1].

Claims Analysis

Claim Structure

Patent claims are the heart of any patent application, defining the scope of the invention. For U.S. Patent 6,689,761, the claims would typically be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Scope

The scope of the claims determines what is protected by the patent. This includes the specific features, processes, or methods described in the claims. For example, if the patent pertains to a technological device, the claims might detail specific components, their interactions, and any unique methods of operation.

Patent Landscape

Related Patents and Family Members

U.S. Patent 6,689,761 may be part of a larger patent family, including other patents that claim priority from the same original application. This is common in cases where multiple patents are filed as continuations or continuations-in-part, each with its own set of claims but linked through a common ancestry[1].

Obviousness-Type Double Patenting (ODP)

A critical aspect of the patent landscape is the potential for obviousness-type double patenting (ODP). This occurs when multiple patents from the same family claim essentially the same invention, with slight variations. The USPTO and courts may invalidate claims under ODP to prevent the extension of patent term through multiple related patents[1].

Determining Inventorship

True and Only Inventors

Correctly identifying the inventors of a patent is vital. U.S. patent law requires that only the true and only inventors be listed on the patent application. This involves a two-step process: conception of the idea and reduction of the idea to practice. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent[2].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

To fully understand the protection offered by U.S. Patent 6,689,761, a Claim Coverage Matrix can be useful. This tool categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Interactive Claim Charts

Interactive claim charts generated by tools like ClaimScape® software can facilitate a quick and accurate review of patent coverage. These charts help technical experts determine whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage may be lacking[3].

Global Trends and Technological Fields

Technological Classification

Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields. Understanding the technological field in which U.S. Patent 6,689,761 is classified can provide insights into broader trends and the competitive landscape[4].

Legal and Regulatory Considerations

Patent Term Adjustments and Extensions

The patent term of U.S. Patent 6,689,761 could be influenced by Patent Term Adjustments (PTA) for USPTO delays during prosecution or Patent Term Extensions (PTE) under specific circumstances. These adjustments can affect the expiration date of the patent and its overall lifespan[1].

Restriction Requirements

During the prosecution of a patent application, the USPTO may issue restriction requirements if multiple independent and distinct inventions are disclosed. This can impact the scope and claims of the patent, as seen in cases like Hyatt v. United States Patent and Trademark Office[5].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of claims is crucial for determining the protection offered by the patent.
  • Patent Landscape: The patent's position within a larger family of patents and potential ODP issues are vital considerations.
  • Inventorship: Correct identification of inventors is essential for the validity of the patent.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts help in analyzing and managing patent claims effectively.
  • Legal Considerations: PTA, PTE, and restriction requirements can significantly impact the patent's term and scope.

FAQs

Q: What is the importance of correctly identifying inventors in a patent application? A: Correctly identifying the true and only inventors is crucial as it ensures the patent remains enforceable and avoids potential challenges or invalidation[2].

Q: How does Obviousness-Type Double Patenting (ODP) affect patent claims? A: ODP can lead to the invalidation of claims if multiple patents from the same family claim essentially the same invention with slight variations, preventing the extension of patent term[1].

Q: What is the purpose of a Claim Coverage Matrix in patent analytics? A: A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Q: How do Patent Term Adjustments (PTA) and Patent Term Extensions (PTE) impact a patent's term? A: PTA and PTE can extend the patent term due to USPTO delays during prosecution or under specific circumstances, affecting the overall lifespan of the patent[1].

Q: What are the implications of restriction requirements during patent prosecution? A: Restriction requirements can limit the scope of the patent by separating multiple independent and distinct inventions, which may need to be pursued in separate applications[5].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Determining Inventorship for US Patent Applications - Oregon State University.
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  5. Hyatt v. United States Patent and Trademark Office - United States Court of Appeals for the Federal Circuit, September 8, 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,689,761

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.